Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1

Bush, 2017, Alternative splicing and the evolution of phenotypic novelty, Philos. Trans. R. Soc. Lond. B Biol. Sci., 372, 20150474, 10.1098/rstb.2015.0474 Marzese, 2018, Alternative splicing and cancer metastasis: prognostic and therapeutic applications, Clin. Exp. Metastasis, 35, 393, 10.1007/s10585-018-9905-y Balli, 2013, Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition, EMBO J., 32, 231, 10.1038/emboj.2012.336 Busch, 2012, Evolution of SR protein and hnRNP splicing regulatory factors, Wiley Interdiscip. Rev. RNA, 3, 1, 10.1002/wrna.100 Jia, 2019, Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation, RNA, 25, 630, 10.1261/rna.068619.118 Wang, 2019, PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23, Int. J. Biol. Sci., 15, 1177, 10.7150/ijbs.33103 Yang, 2018, SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma, Biochim. Biophys. Acta Mol. Cell Res., 1865, 1161, 10.1016/j.bbamcr.2018.05.017 Bomsztyk, 2004, hnRNP K: one protein multiple processes, Bioessays, 26, 629, 10.1002/bies.20048 Chkheidze, 2003, A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins, Mol. Cell Biol., 23, 8405, 10.1128/MCB.23.23.8405-8415.2003 Michael, 1997, The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein, EMBO J., 16, 3587, 10.1093/emboj/16.12.3587 Barboro, 2014, Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression, Cancer Lett., 352, 152, 10.1016/j.canlet.2014.06.019 Gallardo, 2016, Aberrant hnRNP K expression: All roads lead to cancer, Cell Cycle, 15, 1552, 10.1080/15384101.2016.1164372 Peng, 2019, hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing, Cancer Cell Int., 19, 335, 10.1186/s12935-019-1020-x Chen, 2017, Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer, J. Cell Mol. Med., 21, 1266, 10.1111/jcmm.12999 Liu, 2018, MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression, Oncogene, 37, 86, 10.1038/onc.2017.314 Strahl, 2000, The language of covalent histone modifications, Nature, 403, 41, 10.1038/47412 Schor, 2009, Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing, PNAS, 106, 4325, 10.1073/pnas.0810666106 Zhou, 2014, Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms, Nucleic Acids Res., 42, 701, 10.1093/nar/gkt875 Saint-André, 2011, Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons, Nat. Struct. Mol. Biol., 18, 337, 10.1038/nsmb.1995 Choi, 2017, Spindlin 1 is essential for metaphase II stage maintenance and chromosomal stability in porcine oocytes, Mol. Hum. Reprod., 23, 166, 10.1093/molehr/gax005 Li, 2021, Histone code reader SPIN1 is a promising target of cancer therapy, Biochimie, 191, 78, 10.1016/j.biochi.2021.09.002 Wang, 2011, Nucleolar protein Spindlin1 recognizes H3K4 methylation and stimulates the expression of rRNA genes, EMBO Rep., 12, 1160, 10.1038/embor.2011.184 Zhang, 2008, Overexpression of spindlin1 induces metaphase arrest and chromosomal instability, J. Cell. Physiol., 217, 400, 10.1002/jcp.21515 Su, 2014, Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1, Genes Dev., 28, 622, 10.1101/gad.233239.113 Chen, 2016, Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer, J. Pathol., 239, 459, 10.1002/path.4743 Franz, 2015, The histone code reader SPIN1 controls RET signaling in liposarcoma, Oncotarget, 6, 4773, 10.18632/oncotarget.3000 Cao, 2012, Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation, Nucleic Acids Res., 40, 8059, 10.1093/nar/gks504 Revil, 2009, Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform, J. Biol. Chem., 284, 21458, 10.1074/jbc.M109.019711 Maquat, 1995, When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells, RNA, 1, 453 Zhao, 2020, SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer, Cancer Lett., 470, 54, 10.1016/j.canlet.2019.11.032 Lv, 2020, E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer, Mol. Oncol., 14, 2629, 10.1002/1878-0261.12778 Piva, 2012, SpliceAid 2: a database of human splicing factors expression data and RNA target motifs, Hum. Mutat., 33, 81, 10.1002/humu.21609 Paz, 2014, RBPmap: a web server for mapping binding sites of RNA-binding proteins, Nucleic Acids Res., 42, W361, 10.1093/nar/gku406 Santra, 2009, F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage, Nature, 459, 722, 10.1038/nature08011 Alao, 2007, The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention, Mol. Cancer, 6, 24, 10.1186/1476-4598-6-24 Dawson, 2012, Cancer epigenetics: from mechanism to therapy, Cell, 150, 12, 10.1016/j.cell.2012.06.013 Chen, 2017, Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathway, Am. J. Transl. Res., 9, 90 Phoomak, 2019, O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma, Mol. Oncol., 13, 338, 10.1002/1878-0261.12406 Wu, 2012, Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma, Oral Oncol., 48, 516, 10.1016/j.oraloncology.2012.01.005 Guo, 2012, Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis, J. Hematol. Oncol., 5, 37, 10.1186/1756-8722-5-37 Gallardo, 2015, hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies, Cancer Cell, 28, 486, 10.1016/j.ccell.2015.09.001 Moumen, 2005, hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage, Cell, 123, 1065, 10.1016/j.cell.2005.09.032 Takimoto, 1993, Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro, J. Biol. Chem., 268, 18249, 10.1016/S0021-9258(17)46837-2 Ritchie, 2003, Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription, Nucleic Acids Res., 31, 1502, 10.1093/nar/gkg246 Lynch, 2005, hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation, Mol. Cell Biol., 25, 6436, 10.1128/MCB.25.15.6436-6453.2005 Martinez-Contreras, 2007, hnRNP proteins and splicing control, Adv. Exp. Med. Biol., 623, 123, 10.1007/978-0-387-77374-2_8 Popp, 2016, Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine, Cell, 165, 1319, 10.1016/j.cell.2016.05.053 Supek, 2021, To NMD or not to NMD: nonsense-Mediated mRNA decay in cancer and other genetic diseases, Trends Genet., 37, 657, 10.1016/j.tig.2020.11.002 Lindeboom, 2016, The rules and impact of nonsense-mediated mRNA decay in human cancers, Nat. Genet., 48, 1112, 10.1038/ng.3664 Buisson, 2006, The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon, Hum. Mutat., 27, 1024, 10.1002/humu.20384 Zhang, 2018, Nucleolar localization signal and histone methylation reader function is required for SPIN1 to promote rRNA gene expression, Biochem. Biophys. Res. Commun., 505, 325, 10.1016/j.bbrc.2018.09.098 Fang, 2018, SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer, Elife, 7, 10.7554/eLife.31275